Profile picture

Professor Aida Rufatovna Babaeva

Volgograd State Medical University, Volgograd (Russian Federation)
Follow
Logo ESC

Contributor content

Left ventricular diastolic dysfunction in patients with paroxysmal atrial fibrillation
Presentation
Left ventricular diastolic dysfunction in patients with paroxysmal atrial fibrillation
Circulating markers of immune inflammation have diagnostic value in acute coronary syndrome
Presentation
Circulating markers of immune inflammation have diagnostic value in acute coronary syndrome
Acute heart failure in hypertensive crisis: focus on left ventricular diastolic dysfunction
Presentation
Acute heart failure in hypertensive crisis: focus on left ventricular diastolic dysfunction
Circulating markers of vascular wall lesion in asymptomatic atherosclerosis
Presentation
Circulating markers of vascular wall lesion in asymptomatic atherosclerosis
Evaluation of left ventricle diastolic dysfunction in the manifestation of acute heart failure in acute coronary syndrome.
Presentation
Evaluation of left ventricle diastolic dysfunction in the manifestation of acute heart failure in acute coronary syndrome.
Immune-mediated inflammation and acute left ventricular failure in myocardial infarction
Presentation
Immune-mediated inflammation and acute left ventricular failure in myocardial infarction
Circulating markers of endothelial dysfunction as a predictors of cardiovascular events
Presentation
Circulating markers of endothelial dysfunction as a predictors of cardiovascular events
The prognostic value of anti-connective tissue antibodies in coronary heart disease and asymptomatic atherosclerosis
Presentation
The prognostic value of anti-connective tissue antibodies in coronary heart disease and asymptomatic atherosclerosis
Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid artritis
Presentation
Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid artritis
Low-dose anti-cytokine treatment impacts on heart failure with preserved ejection fraction in active rheumatoid arthritis
Presentation
Low-dose anti-cytokine treatment impacts on heart failure with preserved ejection fraction in active rheumatoid arthritis

ESC 365 is supported by